Omalizumab or dupilumab for chronic rhinosinusitis with nasal polyposis Reply Letter

sustainable development goals

publication date

  • January 1, 2021

webpage

published in

start page

  • 413

end page

  • 414

volume

  • 147

issue

  • 1